GlassScriptPhysician profile
Gurpreet Singh
NPI 1659159481
$3,968.74
in general payments reported to CMS, 2019-2025
18 companies · $2,116 in 2025
The $2,116 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,853 · 2025: $2,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,884 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,883.75 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $622.65 | 2024-2025 | |
| Incyte Corporation | $471.28 | 2024-2025 | Opzelura |
| Janssen Biotech, INC. | $438.19 | 2024-2025 | Tremfya |
| Ucb, INC. | $391.65 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $316.10 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $290.51 | 2024-2025 | |
| Leo Pharma INC. | $284.46 | 2025 | Adbry, Anzupgo |
| Amgen INC. | $275.00 | 2024 | Tepezza |
| Pfizer INC. | $223.42 | 2024-2025 | |
| Dermavant Sciences, INC. | $176.83 | 2024 | Vtama |
| Lilly USA, LLC | $106.39 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Genzyme Corporation | $94.24 | 2024-2025 | |
| Galderma Laboratories, L.P. | $80.01 | 2024-2025 | Nemluvio |
| Verrica Pharmaceuticals INC. | $60.14 | 2024 | Ycanth |
| Organon LLC | $39.64 | 2025 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $38.16 | 2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $35.78 | 2025 | Cequa |
| Botanix Sb INC | $24.29 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.